CHALLENGING CASES URINARY RETENTION Charles Chabert.

Slides:



Advertisements
Similar presentations
Università Campus Bio-Medico
Advertisements

Advances in the Management of BPH
No. 091 Bipolar Diathermy for Transurethral Resection of Prostate: 6 year Australian Single Regional Centre Experience Devang Desai (Urology Registrar),
Dr Annie NK Chiu United Christian Hospital Joint Hospital Surgical Grand Round 20 th Apr 2013.
Prostate Cancer Detection in Men with an Initial Diagnosis of Atypical small Acinar Proliferations Dr Charles Chabert The Wollongong Hospital.
Spina bifida Stephen D Mark Christchurch Hospital Christchurch.
What is the place of the Artificial Urinary Sphincter in 2012? Introduction There are an increasing array of surgical options for the treatment of post-prostatectomy.
OnabotulinumtoxinA for Urinary Incontinence from Neurogenic Detrusor Overactivity.
Anmar Nassir, Mohamed El-Azab, Abdulmalik Tayib
Urodynamic Findings and Diagnosis in Aging People
Association Between Diabetes, Obesity, and Short-Term Outcomes Among Patients Surgically Treated for Ankle Fracture by Matthew J. Cavo, Justin P. Fox,
The laboratory investigation of urinary tract infections
Lower Urinary Tract Symptoms in Men
RevoLix New Laser for Surgery
Medical Therapy of Prostate Symptoms (MTOPS) Jeannette Y. Lee, Ph.D. University of Alabama at Birmingham.
Buddhist Tzu Chi General Hospital
Early surgery for proximal femoral fractures is associated with lower complication and mortality rates Parag Kumar Jaiswal Arthroplasty Fellow.
Prostate VTP: Clinical Trial Update
LUTS Shawket Alkhayal Consultant Urological Surgeon Benenden Hospital Tunbridge Wells Nuffield Hospital.
Slide 1 Effect of Combination Therapy with PROSCAR ™† (finasteride, MSD) and Doxazosin on the Risk of Clinical Progression of BPH by Total Baseline Prostate.
Prostate Cancer: A Case for Active Surveillance Philip Kantoff MD Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School.
GERIATRICS : UI Dr. Meg-angela Christi Amores. URINARY INCONTINENCE  major problem for older adults, afflicting up to 30% of community-dwelling elders.
Sandeep Bagla, MD Cardiovascular & Interventional Radiology Inova Alexandria Hospital.
Updated 5-year Biochemical Relapse-Free Survival after Prostate Brachytherapy Jenny P. Nobes St. Luke’s Cancer Centre, The Royal Surrey County Hospital,
PCa Screening New Areas of Research Francesco Montorsi Milan.
Laparoscopic Radical Prostatectomy: Oncological and Functional Outcomes Following Fellowship Training. Introduction Radical Prostatectomy (RP) is a technically.
Analysis of Learning Curve for Minimally Invasive Transforaminal Lumbar Interbody Fusion Byung-Joon Shin, Jae Chul Lee, Hae-Dong Chang, Su-Jin Yun, Yon-Il.
Laparoscopic vs open reversal of Hartmann’s in unselected patients – a teaching centre experience over 8 years including long-term follow-up Nottingham.
Camm J, et al. On Behalf of The SHIFT Gothenburg, Cardiac safety of selective heart rate reduction with Ivabradine in chronic heart failure. Poster, Heart.
Renal Cryoablation. 1. Morbidity 2. Efficacy Cancer Free Survival (NED) Cancer Free Survival (NED) Cancer Specific Survival Cancer Specific Survival Post.
Overactive Bladder Jerry G. Blaivas, MD Clinical Professor of Urology Weil Cornell Medical College New York Presbyterian Hospital Adjunct Professor of.
The GOLIATH Study ..
Reducing avoidable harm in patients with catheters
Anastomosis in IBD Barry Salky, MD FACS Professor of Surgery Chief (Emeritus), Division of Laparoscopic Surgery The Mount Sinai Hospital New York.
REDUCING CATHETER ASSOCIATED URINARY TRACT INFECTIONS CLINICAL EXCELLENCE COMMISSION 2014 ACUTE CATHETERISATION INDICATIONS AND INSERTION OPTIONS.
DANYLO HALYTTSKY LVIV NATIONAL UNIVERSITY (UKRAINE) - 1 UROLOGIC DEPARTMENT OF WROCLAW REGIONAL HOSPITAL (POLAND) - 2 The Term of Expendient Use of Permanent.
Complications of urinary catheterisation
Department of Urology, Guangzhou First Municipal People’s Hospital, Guangzhou Medical College, Guangzhou, China Rubiao Ou, Meng You, Ping Tang, Hui Chen,
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( org/licenses/by-nc/3.0/)
Teaching Module International Continence Society Teaching Module ICS Teaching Module: Measurement of Post- Void Residual Urine A D Asimakopoulos, C De.
Prostate artery embolization (PAE) for bladder outflow obstruction: Results from the first UK prospective study Dyer J P, Bryant T, Coyne J, Flowers D,
1 GreenLight XPS™ Laser Therapy System The GOLIATH Study.
Fig. 3. (A) Bladder compliance and (B) volume of residual urine were evaluated by urodynamic study preoperatively, and at 1, 3, and 12 months after conventional.
International Neurourology Journal 2010;14:
Algorithms of Incontinence Management Men
Urology & Nephrology Center, Mansoura, EGYPT
Cinny Cusack Physiotherapy Manager Mary O’ Reilly Practice Development
Is Brachytherapy 125I still needed in Prostate cancer treatment?
International Neurourology Journal 2016;20:
Hywel Dda University Health Board, UK
Volume 68, Issue 6, Pages e129-e131 (December 2015)
Management of Male OAB; Current Status in Japan
Functional disorders of the lower urinary tract
Rowland Illing  European Urology Supplements 
Volume 63, Issue 4, Pages e53-e56 (April 2013)
Evaluation and Medical Management of Benign Prostatic Hyperplasia
Rowland Illing  European Urology Supplements 
Volume 61, Issue 3, Pages (March 2012)
Volume 57, Issue 4, Pages e41-e42 (April 2010)
Figure 3 Algorithm for the determination of the clinical
P8-2 Rezum water vapour thermal therapy for benign prostatic hyperplasia: early results from the United Kingdom Max Johnston1, Tina Gehring1, James Montgomery1,
Risk Factors for the Development of Bone Metastases in Prostate Cancer
International Neurourology Journal 2015;19:
ML 291 Rev. A.
Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancer  Kenta Onishi, Nobumichi Tanaka, Makito Miyake, Yasushi Nakai,
Hypothesis/ aims of study
What are the Data on 5α-Reductase Inhibitor Treatment of Benign Prostatic Hyperplasia from Everyday Practice?  François Desgrandchamps  European Urology.
Background Bariatric interventions offer a more efficacious and durable weight loss than non-surgical approaches Surgical weight loss procedures are limited.
Flow-mediated and nitrate-mediated dilation in following radial artery catheterisation. Flow-mediated and nitrate-mediated dilation in following radial.
Michael Marberger  European Urology Supplements 
Presentation transcript:

CHALLENGING CASES URINARY RETENTION Charles Chabert

Introduction  Recommendation not to perform PVP on urinary retention in initial series  Submucosal varicosies- problematic bleeding  Older patient group, impaired detrusor contractility Charles Chabert

International GL Users 305 patients treated at 8 centres Mean F/U 4.2 months 63 in retention 120W HPS H Woo et al EU Supplement 7(2007) Charles Chabert

Woo et al No retention (n=242)In retention (n=63) Age Prostate Vol (ml) IPSS Qmax (ml/sec)8.1NR PVR (ml) Charles Chabert H Woo et al EU Supplement 7(2007)

Clinical Outcome Base lineFollow-up IPSS29.7 (n=18)7.8 (n=52) Qmax (ml/sec)Nr16.0 (n=48) PVR719 (n=49)43.3 (n=54) Prostate Vol68.2 9N=57)36.8 (N=57) Charles Chabert H Woo et al EU Supplement 7(2007)

Summary Patients in retention (p<0.01) anticoagulants and large prostates were significantly older than those in the opposing cohort Safe & effective Limited follow-up H Woo et al EU Supplement 7(2007) Charles Chabert

Ruszat et al Eur Urol W KTP n=183In retention (n=70)No retention (n=113) Prostate Vol (cc)60.8 (20-130)53.2 (10-180) Length of Stay (days)5.5 (3-15)5.3 (3-16) Length of IDC1.7 (1-7)1.8 (1-10) Charles Chabert Ruszat et al Eur Urol 2006;50:1040-9

Outcomes In retention (n=70)No retention (n=113) Re catheterisation12.9% (9 patients)10.6% (12 patients) IDC at discharge10% (7 patients)8.8% (10 patients) IDC free at 1 monthAll patients Ruszat et al Eur Urol 2006;50: Charles Chabert

At 24 months (n=16) IPSS Baseline (% improvement)15.5 – 4.4 (71.6%) IPSS QoL (% improvement) (74.3%) Ruszat et al Eur Urol 2006 Ruszat et al Eur Urol 2006;50: Charles Chabert

Complications Reoperation2.9% (2 patients) BN contracture0% Urethral stricture5.7% (5 patients) UTI4.3% Mild-moderate dysuria4.3% Transient Haematuria1.4% Charles Chabert Ruszat et al Eur Urol 2006;50:1040-9

PVP (80W) in men with urinary retention PatientsN=100 Residual Volumes > 1000ml48 Age years70.1 (51-88) Operative time (mins)57.5 (14-150) Cathetrisation time (hours)23.1 (3-72) Rajbabu et al J Endourol Aug 2006;20(suppl. 2): A242 abstract Charles Chabert

Complications Postoperative Haemorrhage2 Ureteric injury1 3 month F/UNo long term IDC Urethral Stricture1 Rajbabu et al J Endourol Aug 2006;20(suppl. 2): A242 abstract Charles Chabert

Summary  Safe and effecctive  Technically more challenging  Not recommended in initial series Charles Chabert